Skip to main content
. 2022 Feb 19;11(2):276. doi: 10.3390/antibiotics11020276

Figure 1.

Figure 1

Prevalence of bacterial co-infections in COVID-19 patients. MRSA: methicillin-resistant S. aureus; MSSA: methicillin-sensitive S. aureus.